Givaudan makes ‘biggest ACI investment to date’ with new production line

Givaudan makes ‘biggest ACI investment to date’ with new production line

Givaudan has invested CHF11 million in a new active cosmetics ingredients fermentation line in Pomacle, France. The extension of production capacity is the company’s most important infrastructure investment in active cosmetic ingredients to date.

“Givaudan acquired Soliance in June 2014 to grow its ACI business and followed this with the acquisition of Induchem in August 2015. The extension of this production line is another example of our commitment to ACI and to our local and global customers who have a growing interest in cosmetics,” explained Gilles Andrier, Givaudan CEO at the inauguration.

The investment comes on the back of news that rival Symrise has cut the ribbon on a new cosmetics ingredients facility in Germany. Givaudan’s investment is said to be in line with the company’s 2020 ambition to become a significant player in the active ingredients market.

 

 

 

Leave a reply

Your email address will not be published. Required fields are marked *